Advertisements

Aurinia Pharmaceuticals Inc (AUPH) Stock Quote

Detailed Quote for Aurinia Pharmaceuticals Inc (AUPH)
$ 6.39   -0.11 (-1.69%) Volume: 1.82m 4:00 PM EDT Jun 22, 2017
After Hours:  $ 6.39 0.00 (0.00%) Volume: 8.64k 5:47 PM EDT Jun 22, 2017
Today 5d 1m 3m 1y more
Last Price
6.39
Change $
0.11
Change %
1.69%
Tick
  
Bid
6.25
Bid Size
600
Ask
6.47
Ask Size
300
Open
6.33
High
6.6368
Low
6.32
Prev Close
6.50
Last Trade
4:00
Volume
1.82m
52 Wk Hi
10.5399999
52 Wk Low
1.73749995
Market Cap
524.62m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
82,100,738
EPS (TTM)
-0.439999997
PE Ratio
N/A
Exchange
NSD
News and Media for Aurinia Pharmaceuticals Inc (AUPH)
Sector News | Topic News
News for Aurinia Pharmaceuticals Inc (AUPH)
Thu, Jun 22, 2017
4:30 PM Aurinia Announces Results of Annual General Meeting - Business Wire
Wed, Jun 21, 2017
7:00 AM Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 in Vancouver, BC - Business Wire
Fri, Jun 16, 2017
8:42 AM Aurinia's voclosporin shows durable response in mid-stage LN study; shares ahead 5% premarket - SeekingAlpha
7:58 AM Voclosporin Remission Data from the Phase IIb AURA-LV Study Highlighted at EULAR 2017 - Business Wire
Thu, Jun 15, 2017
3:15 PM Therapy Focus - Lupus Hopes Build But Data Remain On The Distant Horizon - SeekingAlpha
Mon, Jun 05, 2017
8:00 AM Aurinia Presents Additional Data from Phase IIB AURA-LV Study, Demonstrating Stable Renal Function and Blood Pressure without Electrolyte Complications Through 48 Weeks - Business Wire
Tue, May 30, 2017
4:19 PM Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences - Business Wire
Wed, May 17, 2017
4:02 PM Aurinia Doses First Patient in AURORA Phase 3 Clinical Trial of Voclosporin in Lupus Nephritis - Business Wire
Mon, May 15, 2017
8:00 AM Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights - Business Wire
Tue, May 09, 2017
8:00 AM Pharma Industry Veteran Dr. George Milne Joins Aurinia's Board of Directors - Business Wire
Wed, May 03, 2017
1:07 AM Patience With Schlumberger, Skyworks - Cramer's Lightning Round (5/2/17) - SeekingAlpha
Mon, May 01, 2017
9:57 AM Aurinia Pharmaceuticals Is A Top Pick For H2 2017 - SeekingAlpha
Fri, Apr 28, 2017
6:16 PM Aurinia Pharmaceuticals Inc (AUPH) Pressures Healthcare Sector with a Slide of 3.53% on April 27 - FP News
Wed, Apr 26, 2017
9:17 AM Aurinia to Present at Bloom Burton & Co. Healthcare Conference - Business Wire
Tue, Apr 25, 2017
9:52 AM Aurinia Pharmaceuticals Inc (AUPH) Gives Up 3.81% at Midday on April 24, Pressuring Health Care Stocks - FP News
9:44 AM Aurinia Pharmaceuticals Inc (AUPH) Pressures Healthcare Sector with a Slide of 1.76% on April 24 - FP News
9:42 AM Health Care Sector Feels Weight of 3.18% Slide in Early Trading of Aurinia Pharmaceuticals Inc (AUPH) on April 24 - FP News
Fri, Apr 21, 2017
12:42 PM Aurinia Pharmaceuticals (AUPH) Presents At National Kidney Foundation 2017 (48-Week Data from the AURA-LV Study) - Slideshow - SeekingAlpha
9:17 AM Aurinia's voclosporin meets all 48-week endpoints in mid-stage LN study; shares ahead 5% premarket - SeekingAlpha
9:12 AM Premarket Gainers as of 9:05 am - SeekingAlpha
More News for AUPH >>

Tags for Aurinia Pharmaceuticals Inc

Research stocks or mutual funds related to Aurinia Pharmaceuticals Inc by keywords or tags. Find companies that have a similar focus to AUPH. The keywords below have been associated to AUPH by either user submission or electronic means.